Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVJF) Tax Rate (2016 - 2025)

Historic Tax Rate for Teva Pharmaceutical Industries (TEVJF) over the last 17 years, with Q4 2025 value amounting to 130.0%.

  • Teva Pharmaceutical Industries' Tax Rate fell 1186600.0% to 130.0% in Q4 2025 from the same period last year, while for Dec 2025 it was 12.47%, marking a year-over-year increase of 1803800.0%. This contributed to the annual value of 14.72% for FY2025, which is 379300.0% up from last year.
  • According to the latest figures from Q4 2025, Teva Pharmaceutical Industries' Tax Rate is 130.0%, which was down 1186600.0% from 33.13% recorded in Q3 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Tax Rate ranged from a high of 76.4% in Q2 2022 and a low of 256.1% during Q2 2024
  • In the last 5 years, Teva Pharmaceutical Industries' Tax Rate had a median value of 0.76% in 2022 and averaged 9.38%.
  • In the last 5 years, Teva Pharmaceutical Industries' Tax Rate tumbled by -2578300bps in 2024 and then surged by 2176700bps in 2025.
  • Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Tax Rate stood at 13.71% in 2021, then crashed by -192bps to 12.57% in 2022, then surged by 81bps to 2.34% in 2023, then plummeted by -385bps to 11.34% in 2024, then plummeted by -1047bps to 130.0% in 2025.
  • Its last three reported values are 130.0% in Q4 2025, 33.13% for Q3 2025, and 38.42% during Q2 2025.